Onward Medical Forecast, price target & analysts
Onward Medical Target price 2026 - Analyst rating & recommendation
Onward Medical Classifications & Recommendation
Onward Medical Price Target
| Target Price | €8.87 |
| Price | €2.58 |
| Potential |
244.62%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Onward Medical 2027 .
The average Onward Medical target price is €8.87.
This is
244.62%
register free of charge
€11.55
348.54%
register free of charge
€8.18
217.71%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend Onward Medical to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Onward Medical stock has an average upside potential 2027 of
244.62%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 3.78 | 12.10 |
| 1,543.48% | 220.03% | |
| EBITDA Margin | -1,044.18% | -426.44% |
| 92.93% | 59.16% | |
| Net Margin | -1,105.56% | -477.81% |
| 92.88% | 56.78% |
7 Analysts have issued a sales forecast Onward Medical 2026 . The average Onward Medical sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Onward Medical EBITDA forecast 2026. The average Onward Medical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Onward Medical Analysts have issued a net profit forecast 2026. The average Onward Medical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | -0.90 | -0.83 |
| 12.50% | 7.78% | |
| P/E | negative | |
| EV/Sales | 9.58 |
7 Analysts have issued a Onward Medical forecast for earnings per share. The average Onward Medical EPS is
This results in the following potential growth metrics and future valuations:
Current Onward Medical Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Sep 11 2026 |
| DEGROOF PETERCAM |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| KBC SECURITIES |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| PORTZAMPARC BNP PARIBAS |
Locked
➜
Locked
|
Locked | Jun 29 2026 |
| PORTZAMPARC BNP PARIBAS |
Locked
➜
Locked
|
Locked | Jun 28 2026 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Jun 03 2026 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Sep 11 2026 |
|
Locked
DEGROOF PETERCAM:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
KBC SECURITIES:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
PORTZAMPARC BNP PARIBAS:
Locked
➜
Locked
|
Jun 29 2026 |
|
Locked
PORTZAMPARC BNP PARIBAS:
Locked
➜
Locked
|
Jun 28 2026 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Jun 03 2026 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Jun 02 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
